<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03382730</url>
  </required_header>
  <id_info>
    <org_study_id>0913</org_study_id>
    <nct_id>NCT03382730</nct_id>
  </id_info>
  <brief_title>De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL)</brief_title>
  <acronym>CHORAL</acronym>
  <official_title>A Multi-centered Stepped Wedge Cluster Randomized Controlled Trial of the De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle for Ventilated Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Sinai Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the CHORAL study is to evaluate the de-adoption of oral chlorhexidine and
      the introduction of a bundle of oral care practices on selected outcomes in critically ill
      mechanically ventilated adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infrequent or ineffective oral care can lead to mouth discomfort and lung infection for
      patients treated with ventilators (breathing machines) in intensive care units (ICUs). A
      commonly used mouthwash called chlorhexidine can reduce lung infection but most recent
      evidence shows it may increase the risk of death. In this study 6 participating intensive
      care units (ICUs) will de-adopt oral chlorhexidine and introduce a bundle of oral care
      practices using a multi-faceted educational tool kit. The investigators will measure changes
      in patient-oriented outcomes including mortality, ventilator-associated complications (VACs)
      and oral health status. A concurrent process evaluation will study how the intervention is
      delivered and received by patients and clinicians..
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2018</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multi-centered stepped wedge cluster randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensive Care Unit (ICU) Mortality</measure>
    <time_frame>14 months</time_frame>
    <description>All-cause mortality at time of ICU discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection-related ventilator-associated complications (IVACs)</measure>
    <time_frame>14 months</time_frame>
    <description>Changes in IVACs rates between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Oral Assessment Score (BOAS), Modified</measure>
    <time_frame>14 months</time_frame>
    <description>Changes in oral health between groups. Scores range from 5 (normal) to 20 (severe dysfunction).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Critical Care Pain Observational Tool (CPOT)</measure>
    <time_frame>14 months</time_frame>
    <description>Changes in oropharyngeal pain between groups. CPOT scores range from 0-8 with a score &gt;2 indicating presence of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Dryness - Numeric Rating Intensity Scale (NRS)</measure>
    <time_frame>14 months</time_frame>
    <description>Changes in oral dryness scores between groups. NRS scores range from 0 (no dryness) to 10 (severe dryness).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4200</enrollment>
  <condition>Mortality</condition>
  <condition>Oral Health</condition>
  <condition>Dryness, Mouth</condition>
  <condition>Pain, Orofacial</condition>
  <arm_group>
    <arm_group_label>Oral Chlorhexidine Mouth Rinse</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Application of chlorhexidine gluconate mouth rinse per unit protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>De-Adoption of Oral Chlorhexidine Mouth Rinse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No application of chlorhexidine gluconate mouth rinse. Oral care bundle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chlorhexidine Mouth Rinse</intervention_name>
    <description>Oral chlorhexidine gluconate oral rinse</description>
    <arm_group_label>Oral Chlorhexidine Mouth Rinse</arm_group_label>
    <other_name>Chlorhexidine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chlorhexidine Mouth Rinse De-Adoption</intervention_name>
    <description>Multifaceted education and audit/feedback.</description>
    <arm_group_label>De-Adoption of Oral Chlorhexidine Mouth Rinse</arm_group_label>
    <other_name>De-adopt chlorhexidine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who receive mechanical ventilation in the participating ICUs.

        Exclusion Criteria:

          -  Does not meet inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Cuthbertson, MD FRCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Dale, RN PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre; University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Carbone, MSc</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>2389</phone_ext>
    <email>sarah.carbone@sunnybrook.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Craig Dale, RN PhD</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>2387</phone_ext>
    <email>craig.dale@sunnybrook.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Burry, PharmD</last_name>
      <email>lburry@mtsinai.on.ca</email>
    </contact>
    <investigator>
      <last_name>Lisa Burry, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Detsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Orla M Smith, RN PhD</last_name>
      <email>Smitho@smh.ca</email>
    </contact>
    <investigator>
      <last_name>Orla M Smith, RN PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan O Friedrich, MD FRCP(C) DPhil</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Craig Dale, RN PhD</last_name>
      <email>craig.dale@utoronto.ca</email>
    </contact>
    <investigator>
      <last_name>Brian Cuthbertson, MB ChB MD FRCA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Craig Dale, RN PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eddy Fan, MD PhD</last_name>
      <email>eddy.fan@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Eddy Fan, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clare Fielding, RN MN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Victoria McCredie, MD PhD</last_name>
      <email>Victoria.McCredie@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Victoria McCredie, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2017</study_first_submitted>
  <study_first_submitted_qc>December 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2017</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Craig M. Dale</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xerostomia</mesh_term>
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

